Voriconazole In situ Gel for Ocular Drug Delivery

Fungal keratitis is an important cause of vision loss in developing countries characterized by a corneal epithelial defect and inflammation of the corneal stroma [17]. Currently, fungal keratitis remains a perplexing diagnostic challenge and a difficult management problem for ophthalmologists [7]. Various factors responsible for development of fungal karatitis includes ocular trauma, contamination of corneal lesions by soil and plant material, use of broad spectrum antibiotics and steroids use of contact lenses. Another important factor to be considered supportive to fungal karatitis are climatic conditions mainly temperate climate and tropical climate [10]. Early diagnosis of fungal keratitis and its treatment is important in preventing Abstract

[1]  Liu Shash Recent Advances in Ophthalmic Drug Delivery System , 2015 .

[2]  I. Singh,et al.  Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis , 2014, Journal of pharmaceutics.

[3]  P. Pawar,et al.  Hp-β-CD-Voriconazole In Situ Gelling System for Ocular Drug Delivery: In Vitro, Stability, and Antifungal Activities Assessment , 2013, BioMed research international.

[4]  Osama A. Soliman,et al.  Formulation and Physical Characterization of a Novel Sustained-Release Ophthalmic Delivery System for Sparfloxacin: the Effect of the Biological Environment , 2013 .

[5]  A. Bozkır,et al.  Thermosensitive and pH induced in situ ophthalmic gelling system for ciprofloxacin hydrochloride: hydroxypropyl-beta-cyclodextrin complex. , 2012, Acta poloniae pharmaceutica.

[6]  Rathapon Asasutjarit,et al.  Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. , 2011, International journal of pharmaceutics.

[7]  Nirmal Jayabalan,et al.  Microscopic and spectroscopic evaluation of novel PLGA-chitosan Nanoplexes as an ocular delivery system. , 2011, Colloids and surfaces. B, Biointerfaces.

[8]  Aparna Singh In Situ Gelling Ophthalmic Drug Delivery System For Glaucoma , 2011 .

[9]  Yadollah Omidi,et al.  Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function – a review , 2010 .

[10]  V. H. Sarmento,et al.  A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  T. Lifshitz,et al.  [Treatment of fungal keratitis by penetrating keratoplasty]. , 2010, Harefuah.

[12]  K. Rathore,et al.  IN­SITU GELLING OPHTHALMIC DRUG DELIVERY SYSTEM: AN OVERVIEW , 2010 .

[13]  D. Banerjee,et al.  Epidemiological profile of fungal keratitis in urban population of West Bengal, India , 2009, Oman journal of ophthalmology.

[14]  I. Brownlee,et al.  Alginate as a Source of Dietary Fiber , 2005, Critical reviews in food science and nutrition.

[15]  P. Wesseling,et al.  Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  C. Meyer Voriconazole Treatment of Fungal Scleritis and Epibulbar Abscess Resulting From Scleral Buckle Infection , 2003 .

[17]  A. El-Kamel In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. , 2002, International journal of pharmaceutics.

[18]  E. Cohen,et al.  Spectrum of Fungal Keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania , 2000, Cornea.

[19]  J. Carlfors,et al.  Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.